Cart
sales@molnova.com
Lucigenin
CAS No. 2315-97-1
Lucigenin( NSC-151912 | L-6868 )
Catalog No. M24059 CAS No. 2315-97-1
Lucigenin (L-6868) is a chemiluminescent probe used to indicate the presence of endogenously generated superoxide anion radicals in cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 27 | In Stock |
|
| 100MG | 41 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLucigenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionLucigenin (L-6868) is a chemiluminescent probe used to indicate the presence of endogenously generated superoxide anion radicals in cells.
-
DescriptionLucigenin (L-6868) is a chemiluminescent probe used to indicate the presence of endogenously generated superoxide anion radicals in cells.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC-151912 | L-6868
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2315-97-1
-
Formula Weight510.5
-
Molecular FormulaC28H22N4O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:80mg/mL (156.71 mM)
-
SMILESC[n+](c1ccccc11)c(cccc2)c2c1-c1c(cccc2)c2[n+](C)c2ccccc12.[O-][N+]([O-])=O.[O-][N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li Y, et al. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem. 1998 Jan 23;273(4):2015-23.
molnova catalog
related products
-
Ropidoxuridine
Ropidoxuridine (IPdR) is a novel, orally available halogenated thymidine analogue that holds promise as a sensitizer for human tumors.
-
Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
-
SP1
SP1
